ZAI LAB：監査委員会の措置の通知と2024年第3四半期決算発表の公表日

HKEX10/31 18:36

Is Zai Lab (NASDAQ:ZLAB) Using Too Much Debt?

Simply Wall St10/30 02:46

Zai Lab Phase 3 Study Of KarXT In Schizophrenia Meets Primary Goal

RTTNews10/29 21:26

Zai Lab Reports Topline Data From Phase 3 Bridging Trial Evaluating KarXT For Schizophrenia In China; KarXT Demonstrated A Statistically Significant 9.2-Point Reduction In PANSS Total Score From Baseline At Week 5 Compared To Placebo, Trial Met All...

Benzinga10/29 19:39

Cantor Fitzgerald Reiterates Overweight on Zai Lab

Benzinga10/25 23:45

Zai Lab Analyst Ratings

Benzinga10/25 23:43